SCHEMBL2146282

SCHEMBL2146282

CCCCCC1OC(=O)CC1C

nearest known ligand 0.47

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.47
PRKCA P17252 7/20 0.44
PPARG P37231 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 1/20 0.41
FASN P49327 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30754370 1.00 CYP1A2 (0.47) CYP1A2PRKCAPPARGSMN1; SMN2POLB
SCHEMBL2512382 0.98 CYP1A2 (0.50) CYP1A2PRKCAPPARGPOLBFASN
SCHEMBL18086466 0.98 CYP1A2 (0.50) CYP1A2PRKCAPPARGPOLBFASN
SCHEMBL1773872 0.98 CYP1A2 (0.50) CYP1A2PRKCAPPARGPOLBFASN
SCHEMBL2515618 0.98 CYP1A2 (0.50) CYP1A2PRKCAPPARGPOLBFASN
SCHEMBL1793652 0.98 CYP1A2 (0.50) CYP1A2PRKCAPPARGPOLBFASN
SCHEMBL7178100 0.94 SMN1; SMN2 (0.43) CYP1A2PRKCAPPARGSMN1; SMN2
SCHEMBL114791 0.94 SMN1; SMN2 (0.43) CYP1A2PRKCAPPARGSMN1; SMN2
SCHEMBL14994441 0.94 SMN1; SMN2 (0.43) CYP1A2PRKCAPPARGSMN1; SMN2
SCHEMBL7187580 0.94 SMN1; SMN2 (0.43) CYP1A2PRKCAPPARGSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 236 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4739734-A1 PROCESS FOR THE MANUFACTURE OF THERMOSET POLYESTER FOAMS Saint-Gobain Isover (FR) 2026-05-13 EP claimed
US-12559703-B2 Fragrance composition GIVAUDAN SA (CH) 2026-02-24 US claimed
EP-4583708-A1 ARTHROPOD CONTROL COMPOSITIONS Firmenich SA (CH) 2025-07-16 EP claimed
WO-2025008342-A1 PROCESS FOR THE MANUFACTURE OF THERMOSET POLYESTER FOAMS SAINT-GOBAIN ISOVER (FR) 2025-01-09 WO claimed
US-20240400784-A1 Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition LG CHEM, LTD. (KR) 2024-12-05 US claimed
US-20240392094-A1 Method for Screening Solvent for Polyvinyl Chloride Extraction, Recycling Method for Waste Material, and Recycled Polyvinyl Chloride and Composition LG CHEM, LTD. (KR) 2024-11-28 US claimed
US-20240173230-A1 FRAGRANCE COMPOSITION GIVAUDAN SA (CH) 2024-05-30 US claimed
WO-2024084006-A1 ARTHROPOD CONTROL COMPOSITIONS FIRMENICH SA (CH) 2024-04-25 WO claimed
EP-4319715-A1 FRAGRANCE COMPOSITION Givaudan SA (CH) 2024-02-14 EP claimed
US-20230151305-A1 FRAGRANCE COMPOSITION SA, GIVAUDAN (CH) 2023-05-18 US claimed
EP-2167025-A2 PRESERVATIVE-FREE COMPOSITIONS COMPRISING CINNAMIC OR ANISIC ACID AND A BENZALDEHYDE (DERIVATIVE) Givaudan SA (CH) 2010-03-31 EP claimed
WO-2009000097-A2 PRESERVATIVE-FREE COMPOSITIONS COMPRISING CINNAMIC OR ANISIC ACID AND A BENZALDEHYDE (DERIVATIVE) GIVAUDAN SA (CH) 2008-12-31 WO claimed
US-20080021098-A1 Antifungal Compositions GIVAUDAN SA (CH) 2008-01-24 US claimed
US-7105628-B2 Compositions for golf equipment ACUSHNET COMPANY (US) 2006-09-12 US claimed
WO-2005079573-A1 ANTIFUNGAL COMPOSITIONS GIVAUDAN SA (CH) 2005-09-01 WO claimed
US-20040220378-A1 Compositions for golf equipment JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT 2004-11-04 US claimed
US-6369248-B1 HYDROXY ESTERS FOR PERFUMES GIVAUDAN SA (CH) 2002-04-09 US claimed
EP-0989970-A1 FRAGRANCE PRECURSOR COMPOUNDS GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 2000-04-05 EP claimed
EP-0980863-A1 Oxime carboxylic acid derivatives Givaudan Roure (International) S.A. (CH) 2000-02-23 EP claimed
WO-1998058899-A1 FRAGRANCE PRECURSOR COMPOUNDS GIVAUDAN-ROURE (INTERNATIONAL) S.A. (CH) 1998-12-30 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080021098-A1 Antifungal Compositions ERG28, DPM1, SORD CYP1A2 250/4885PRKCA 4017/4885PPARG 1366/4885
US-12559703-B2 Fragrance composition DHCR24, OPRD1, OR10J3 CYP1A2 234/4885PRKCA 4116/4885PPARG 2671/4885
US-20240173230-A1 FRAGRANCE COMPOSITION FABP2, FABP5, FAAH2 CYP1A2 148/4885PRKCA 4564/4885PPARG 180/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.